A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 7,118,371 shares of CORT stock, worth $200 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
7,118,371
Previous 6,725,871 5.84%
Holding current value
$200 Million
Previous $218 Million 17.92%
% of portfolio
0.28%
Previous 0.34%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$21.1 - $27.46 $8.28 Million - $10.8 Million
392,500 Added 5.84%
7,118,371 $179 Million
Q4 2023

Feb 13, 2024

BUY
$24.82 - $32.88 $2.76 Million - $3.65 Million
111,000 Added 1.68%
6,725,871 $218 Million
Q3 2023

Nov 14, 2023

SELL
$21.97 - $33.8 $1.87 Million - $2.88 Million
-85,100 Reduced 1.27%
6,614,871 $180 Million
Q2 2023

Aug 11, 2023

SELL
$21.44 - $25.15 $1.89 Million - $2.22 Million
-88,098 Reduced 1.3%
6,699,971 $149 Million
Q1 2023

May 12, 2023

SELL
$19.2 - $24.47 $9.62 Million - $12.3 Million
-500,802 Reduced 6.87%
6,788,069 $147 Million
Q4 2022

Feb 13, 2023

BUY
$19.95 - $29.96 $1.82 Million - $2.74 Million
91,400 Added 1.27%
7,288,871 $148 Million
Q3 2022

Nov 14, 2022

SELL
$24.7 - $29.12 $15.7 Million - $18.5 Million
-636,400 Reduced 8.12%
7,197,471 $185 Million
Q2 2022

Aug 12, 2022

BUY
$17.33 - $25.3 $1.1 Million - $1.6 Million
63,355 Added 0.82%
7,833,871 $186 Million
Q1 2022

May 13, 2022

SELL
$16.53 - $25.21 $4.18 Million - $6.38 Million
-253,100 Reduced 3.15%
7,770,516 $175 Million
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $3.83 Million - $5.23 Million
-224,225 Reduced 2.72%
8,023,616 $159 Million
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $5.4 Million - $6.18 Million
-274,355 Reduced 3.22%
8,247,841 $162 Million
Q2 2021

Aug 13, 2021

SELL
$19.97 - $24.43 $5.02 Million - $6.15 Million
-251,600 Reduced 2.87%
8,522,196 $187 Million
Q1 2021

May 13, 2021

SELL
$23.49 - $30.56 $13.3 Million - $17.3 Million
-567,700 Reduced 6.08%
8,773,796 $209 Million
Q4 2020

Feb 10, 2021

SELL
$16.78 - $27.3 $4.44 Million - $7.22 Million
-264,500 Reduced 2.75%
9,341,496 $244 Million
Q3 2020

Nov 13, 2020

BUY
$12.46 - $19.98 $8.55 Million - $13.7 Million
686,000 Added 7.69%
9,605,996 $167 Million
Q2 2020

Aug 13, 2020

BUY
$11.0 - $18.26 $6.79 Million - $11.3 Million
617,155 Added 7.43%
8,919,996 $150 Million
Q1 2020

May 14, 2020

BUY
$10.11 - $14.04 $5.41 Million - $7.51 Million
534,627 Added 6.88%
8,302,841 $98.7 Million
Q4 2019

Feb 13, 2020

BUY
$12.06 - $16.96 $15 Million - $21.1 Million
1,244,005 Added 19.07%
7,768,214 $94 Million
Q3 2019

Nov 13, 2019

BUY
$10.41 - $14.66 $9.72 Million - $13.7 Million
933,700 Added 16.7%
6,524,209 $92.2 Million
Q2 2019

Aug 12, 2019

BUY
$9.78 - $12.76 $5.21 Million - $6.8 Million
532,700 Added 10.53%
5,590,509 $62.3 Million
Q1 2019

May 14, 2019

BUY
$10.03 - $15.71 $4.12 Million - $6.45 Million
410,600 Added 8.84%
5,057,809 $59.4 Million
Q4 2018

Feb 13, 2019

BUY
$11.29 - $17.19 $52.5 Million - $79.9 Million
4,647,209 New
4,647,209 $62.1 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.